Deluca H F
Clin Endocrinol (Oxf). 1977 Dec;7 Suppl:1s-17s. doi: 10.1111/j.1365-2265.1977.tb03356.x.
During the past decade, an explosion of information has become available on the metabolism and function of vitamin D which is of great importance to clinicians in the treatment of metabolic bone disease. We have learned that vitamin D is the precursor of at least one hormone and that this hormone carries out functions in calcium and phosphorus metabolism bringing about mineralization of bone on one hand, and the prevention of hypocalcaemic tetany on the other. It may also function in the prevention of such degenerative bone diseases as osteoporosis. An important analogue of this hormone, 1alpha-hydroxyvitamin D3 has been prepared and is used successfully in the treatment of a variety of clinical conditions. This presentation will summarize these findings and their possible implications in these metabolic bone diseases.
在过去十年间,有关维生素D代谢和功能的信息大量涌现,这对临床医生治疗代谢性骨病至关重要。我们已经了解到,维生素D是至少一种激素的前体,并且这种激素在钙和磷的代谢中发挥作用,一方面促使骨矿化,另一方面预防低钙血症性手足搐搦。它或许还在预防诸如骨质疏松症等退行性骨病方面发挥作用。这种激素的一种重要类似物,即1α-羟基维生素D3已被制备出来,并成功用于治疗多种临床病症。本报告将总结这些发现及其在这些代谢性骨病中可能产生的影响。